The impact of gender and left atrial blood stasis on adiponectin levels in non-valvular atrial fibrillation

International Journal of Cardiology

Volumn 181, Issue , 2015, Pages 207-212

  Cohoon, Kevin P ^a   Mazur, Matylda ^a   McBane, Robert D ^a   Ketha, Siva ^a   Ammash, Naser ^a   Wysokinski, Waldemar E ^a  

^a MAYO CLINIC   (United States)

Author keywords

Adiponectin; Atrial fibrillation; Gender; Left atrial appendage thrombus

Indexed keywords

ADIPONECTIN; ADIPOQ PROTEIN, HUMAN; BIOLOGICAL MARKER;

ADULT; AGE DISTRIBUTION; AGED; AREA UNDER THE CURVE; ARTICLE; CARDIOVASCULAR PARAMETERS; CASE CONTROL STUDY; CHADS2 SCORE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HEART DISEASE; HEART LEFT ATRIAL APPENDAGE THROMBUS; HEART LEFT ATRIAL BLOOD STASIS; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LEFT ATRIAL APPENDAGE EMPTYING VELOCITY; LEFT ATRIUM VOLUME INDEX; MAJOR CLINICAL STUDY; MALE; NON VALVULAR ATRIAL FIBRILLATION; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SOLID PHASE ENZYME LINKED IMMUNOSORBENT ASSAY; SPONTANEOUS ECHOCARDIOGRAPHIC CONTRAST; VISUAL ANALOG SCALE; ATRIAL FIBRILLATION; BLOOD; HEART ATRIUM; HEMOSTASIS; MIDDLE AGED; PHYSIOLOGY; SEXUAL DEVELOPMENT;

ADIPONECTIN; AGED; ATRIAL FIBRILLATION; BIOMARKERS; FEMALE; HEART ATRIA; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; SEX CHARACTERISTICS;

EID: 84947202347     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.12.022     Document Type: Article

References (38)

1. C.L. Ogden, M.D. Carroll, and L.R. Curtin Prevalence of overweight and obesity in the United States, 1999-2004 JAMA 295 2006 1549 1555
2. A.S. Go, E.M. Hylek, and K.A. Phillips Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (atria) study JAMA 285 2001 2370 2375
3. T.J. Wang, H. Parise, and D. Levy Obesity and the risk of new-onset atrial fibrillation JAMA 292 2004 2471 2477
4. U.B. Pajvani, X. Du, and T.P. Combs Structure-function studies of the adipocyte-secreted hormone acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity J. Biol. Chem. 278 2003 9073 9085
5. S.H. Han, M.J. Quon, J.A. Kim, and K.K. Koh Adiponectin and cardiovascular disease: response to therapeutic interventions J. Am. Coll. Cardiol. 49 2007 531 538
6. K. Fujita, N. Maeda, and M. Sonoda Adiponectin protects against angiotensin ii-induced cardiac fibrosis through activation of ppar-alpha Arterioscler. Thromb. Vasc. Biol. 28 2008 863 870
7. S.T. Page, K.L. Herbst, and J.K. Amory Testosterone administration suppresses adiponectin levels in men J. Androl. 26 2005 85 92
8. M.S. Boyne, N.R. Bennett, and R.S. Cooper Sex-differences in adiponectin levels and body fat distribution: longitudinal observations in Afro-Jamaicans Diabetes Res. Clin. Pract. 90 2010 e33 e36
9. M. Cnop, P.J. Havel, and K.M. Utzschneider Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex Diabetologia 46 2003 459 469
10. K. Hotta, T. Funahashi, and Y. Arita Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients Arterioscler. Thromb. Vasc. Biol. 20 2000 1595 159917
11. U. Salmenniemi, E. Ruotsalainen, and J. Pihlajamaki Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome Circulation 110 2004 3842 3848
12. Y. Iwashima, T. Katsuya, and K. Ishikawa Hypoadiponectinemia is an independent risk factor for hypertension Hypertension 43 2004 1318 1323
13. M. Kumada, S. Kihara, and S. Sumitsuji Association of hypoadiponectinemia with coronary artery disease in men Arterioscler. Thromb. Vasc. Biol. 23 2003 85 8922
14. O. Assar Low adiponectin level may contribute to higher incidence of postcardiac surgery atrial fibrillation in obese patients Ann. Thorac. Surg. 93 2012 1762 1763 (author reply 1763)
15. M. Shimano, R. Shibata, and Y. Tsuji Circulating adiponectin levels in patients with atrial fibrillation Circ. J. 72 2008 1120 1124
16. J. Ybarra, E. Resmini, and F. Planas Relationship between adiponectin and left atrium size in uncomplicated obese patients: adiponectin, a link between fat and heart Obes. Surg. 19 2009 1324 1332
17. S.Y. Shin, H.S. Yong, and H.E. Lim Total and interatrial epicardial adipose tissues are independently associated with left atrial remodeling in patients with atrial fibrillation J. Cardiovasc. Electrophysiol. 22 2011 647 655
18. D. Hernandez-Romero, E. Jover, and F. Marin The prognostic role of the adiponectin levels in atrial fibrillation Eur. J. Clin. Invest. 43 2013 168 173
19. N. Ammash, E.A. Konik, and R.D. McBane Left atrial blood stasis and Von Willebrand factor-ADAMTS13 homeostasis in atrial fibrillation Arterioscler. Thromb. Vasc. Biol. 31 2011 2760 2766
20. R.M. Melduni, K. Chandrasekaran, and P.A. Friedman Does left atrial appendage peak emptying flow velocity predict the electrical energy required to achieve successful direct-current cardioversion in patients with persistent atrial fibrillation? J. Am. Soc. Echocardiogr. 20 2007 1004 1008
21. W.E. Wysokinski, N. Ammash, F. Sobande, H. Kalsi, D. Hodge, and R.D. McBane Predicting left atrial thrombi in atrial fibrillation Am. Heart J. 159 2010 665 671
22. D. Fatkin, R.P. Kelly, and M.P. Feneley Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo J. Am. Coll. Cardiol. 23 1994 961 969
23. Jae K. Oh, James B. Seward, and A. Jamil Tajik The Echo Manual Third edition 1994 Lippincott Williams and Wilkins 7 58
24. B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich, and M.J. Radford Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation JAMA 285 2001 2864 2870
25. S. Genuth, K.G. Alberti, and P. Bennett Follow-up report on the diagnosis of diabetes mellitus Diabetes Care 26 2003 3160 3167
26. R.F. Gillum, S.P. Fortmann, R.J. Prineas, and T.E. Kottke International diagnostic criteria for acute myocardial infarction and acute stroke Am. Heart J. 108 1984 150 158
27. World health organization WHO: Global Database on Body Mass Index 2006
28. V. Fuster, L.E. Ryden, and D.S. Cannom ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation Europace 8 2006 651 745
29. G.Y. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, and H.J. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation Chest 137 2010 263 272
30. F. Ziemke, and C.S. Mantzoros Adiponectin in insulin resistance: lessons from translational research Am. J. Clin. Nutr. 91 2010 258S 261S
31. H. Kato, H. Kashiwagi, and M. Shiraga Adiponectin acts as an endogenous antithrombotic factor Arterioscler. Thromb. Vasc. Biol. 26 2006 224 23045
32. A.T. Turer, A. Khera, and C.R. Ayers Adipose tissue mass and location affect circulating adiponectin levels Diabetologia 54 2011 2515 2524
33. C. Bélanger, F.S. Hould, S. Lebel, S. Biron, G. Brochu, and A. Tchernof Omental and subcutaneous adipose tissue steroid levels in obese men Steroids 71 2006 674 682
34. A. Michaud, M.M. Boulet, A. Veilleux, S. Noel, G. Paris, and A. Tchernof Abdominal subcutaneous and omental adipocyte morphology and its relation to gene expression, lipolysis and adipocytokine levels in women Metabolism 63 2014 372 381 (PMID:24369916)
35. H. Takano, J.E. Obata, and Y. Kodama Adiponectin is released from the heart in patients with heart failure Int. J. Cardiol. 132 2009 221 226
36. C. Kistorp, J. Faber, and S. Galatius Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure Circulation 112 2005 1756 1762
37. T. Nakamura, Y. Kodama, and H. Takano Increase in circulating levels of adiponectin after treatment with statin and fibrate in patients with coronary artery disease and hyperlipidemia Atherosclerosis 193 2007 449 451
38. E. ter Avest, E.J. Abbink, J. de Graaf, C.J. Tack, and A.F. Stalenhoef Effect of rosuvastatin on insulin sensitivity in patients with familial combined hyperlipidaemia Eur. J. Clin. Invest. 35 2005 558 564